4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-035580
Director sold 1,400 shares at $350.03 ($490,044)
- Director acquired 1,400 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRIEDMAN PAUL A Director | 2025-07-18 | Option exercise 10b5-1 | +1,400 | $9.45 | $13,230 | 188,564 | D |
| FRIEDMAN PAUL A Director | 2025-07-18 | Sale 10b5-1 | −1,400 | $350.03 | $490,044 | 187,164 | D |
| Derivatives | |||||||
| FRIEDMAN PAUL A Director | 2025-07-18 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,400 | 175,980 | D | ||
| Open-market sales · 1,400 sh · avg $350.03 · $490,044 | |||||||
Loading xslF345X05/wk-form4_1753218411.xml…